(Q38335320)

2 September 2017

Inhibition of p53-mediated transcriptional responses by mithramycin A. (English)

1 reference

2 September 2017

George Koutsodontis

1

1 reference

PubMed ID

15489892

2 September 2017

Dimitris Kardassis

series ordinal

2

1 reference

PubMed ID

15489892

2 September 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

2 September 2017

1 reference

2 September 2017

23

1 reference

2 September 2017

57

1 reference

2 September 2017

9190-9200

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208141

2 September 2017

0 references

cites work

Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

p53 in embryonic development: maintaining a fine balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Cdk inhibitors in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Durhamycin A, a potent inhibitor of HIV Tat transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Direct physical interactions between HNF-4 and Sp1 mediate synergistic transactivation of the apolipoprotein CIII promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Molecular interaction map of the mammalian cell cycle control and DNA repair systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

p53 mutations in human immortalized epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Membrane interaction of an antitumor antibiotic, mithramycin, with anionic phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Mithramycin blocks protein binding and function of the SV40 early promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Role of protein kinase C and the Sp1-p53 complex in activation of p21(WAF-1) expression by 12-O-tetradecanoylphorbol-13-acetate in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

PUMA mediates the apoptotic response to p53 in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

PUMA induces the rapid apoptosis of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

p21 is a component of active cell cycle kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

Role of magnesium ion in mithramycin-DNA interaction: binding of mithramycin-Mg2+ complexes with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

7 January 2021

SMAD proteins transactivate the human ApoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

7 January 2021

Interaction of the DNA-binding antitumor antibiotics, chromomycin and mithramycin with erythroid spectrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

7 January 2021

Mithramycin selectively inhibits transcription of G-C containing DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

7 January 2021

Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208141

7 January 2021

Dimensions Publication ID

Identifiers

DOI

10.1038/SJ.ONC.1208141

0 references

0 references

1 reference

PubMed ID

15489892